New Medical Procedure to Treat Severe Heartburn Featured in Live WebMD Interactive Educational Event.Business Editors/Health/Medical Writers MURRAY HILL, N.J.--(BW HealthWire)--July 11, 2000 Wednesday, July 12, 8:00 PM Eastern Standard Time C. R. Bard C. R. Bard, Inc. (NYSE: BCR) is one of the large S&P 500 companies of the United States, a surgical specialties and hospital medical device manufacturer in Murray Hill, New Jersey. It is named after its founder, who sold the company within only a few years of its founding. , Inc. (NYSE-BCR) is delighted to report that Dr. Anthony Starpoli, MD, Director of the Gastrointestinal Reflux Disease (GERD GERD gastroesophageal reflux disease. GERD abbr. gastroesophageal reflux disease GERD ) Unit at St. Vincent's Hospital Hospital:
New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. , will conduct an independent, interactive educational event, "Treatments for Heartburn/GERD" on WebMD(TM), Wednesday, July 12, at 8:00 PM Eastern Time. During the 60-minute live webcast, Dr. Strapoli will answer questions about a new procedure to treat GERD with the Bard EndoCinch(TM) device. Though admission to the event is free, participants must first register to become a member of the WebMD Health Community. This event will be held in the Nutritional Health Auditorium, which opens one hour before the event begins. For more details on the event, visit http://my.webmd.com/calendar. GERD is a chronic digestive condition in which stomach acid flows back up into the esophagus, causing severe heartburn. Prolonged exposure to reflux can also lead to ulceration, asthma and strictures and may promote the development of esophageal cancer. Studies suggest that 60 million people have monthly heartburn and approximately 15 million experience the condition on a daily basis. The new Bard EndoCinch system, developed and marketed by C. R. Bard, Inc., received Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) clearance on April 5, 2000. Patients with severe heartburn should consult with their physician to discuss their condition and appropriate treatment options. "The new Endo Luminal Gastroplication procedure provides an effective, minimally invasive option for the treatment of chronic heartburn. The ideal patient for the new treatment is one who experiences reflux-like symptoms at least twice a week and is dependent on medications to treat their GERD," Dr. Starpoli said. Dr. Starpoli is an attending physician at St. Vincent's Hospital and Medical Center of New York and an Assistant Professor of Medicine at New York Medical College New York Medical College is a center for graduate medical education located in Westchester County, a suburb half an hour north of New York City. This private university comprises the School of Medicine, which grants the M.D. . Visit Dr. Starpoli's web site at www.refluxcare.com. Healtheon/WebMD (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :HLTH HLTH Health HLTH WebMD Corporation (stock abbreviation, AMEX) ) is an end-to-end internet healthcare company connecting physicians and consumers to the entire healthcare industry. Live interactive events on www.mywebmd.com, feature monthly program topics including: Cancer Connection, Cancer Update, Men's Health Place, Women's Health Place and Health in Your Mature Years. C. R. Bard, Inc. is not affiliated with Health/WebMD. C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill, New Jersey
Bard Interventional Products, a division of Bard, is located in Billerica, Massachusetts, and specializes in the field of gastroenterology. For more than ten years, Bard Interventional Products has been developing minimally invasive diagnostic and therapeutic products used in conjunction with procedures requiring flexible endoscopy. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion